| Primary pancreatic lymphoma–pancreatic tumours that are potentially curable without resection, a retrospective review of four cases PS Grimison, MT Chin, ML Harrison, D Goldstein BMC cancer 6, 1-9, 2006 | 77 | 2006 |
| Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer MH Pourgholami, M Szwajcer, M Chin, W Liauw, J Seef, P Galettis, ... Cancer chemotherapy and pharmacology 65, 597-605, 2010 | 76 | 2010 |
| Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue CX Sandler, D Goldstein, S Horsfield, BK Bennett, M Friedlander, ... Journal of Pain and Symptom Management 54 (1), 74-84, 2017 | 71 | 2017 |
| Dose selection, pharmacokinetics, and pharmacodynamics of BRAF inhibitor dabrafenib (GSK2118436) GS Falchook, GV Long, R Kurzrock, KB Kim, HT Arkenau, MP Brown, ... Clinical Cancer Research 20 (17), 4449-4458, 2014 | 70 | 2014 |
| Patient, general practitioner and oncologist views regarding long-term cancer shared care H Schütze, M Chin, D Weller, MF Harris Family practice 35 (3), 323-329, 2018 | 49 | 2018 |
| Lipid lowering therapy in patients with HIV infection M McBride, MTM Chin, SM Lee, B Kelly The Lancet 352 (9142), 1782-1783, 1998 | 35 | 1998 |
| Using behaviour change and implementation science to address low referral rates in oncology JC Long, D Debono, R Williams, E Salisbury, S O’Neill, E Eykman, ... BMC health services research 18, 1-16, 2018 | 28 | 2018 |
| Advanced cancer patients’ attitudes towards, and experiences with, screening for somatic mutations in tumours: a qualitative study R Liang, B Meiser, S Smith, NA Kasparian, CR Lewis, M Chin, GV Long, ... European Journal of Cancer Care 26 (6), e12600, 2017 | 28 | 2017 |
| Dexamethasone modifies cystatin c-based diagnosis of acute kidney injury during cisplatin-based chemotherapy TJ Pianta, JW Pickering, L Succar, M Chin, T Davidson, NA Buckley, ... Kidney and Blood Pressure Research 42 (1), 62-75, 2017 | 21 | 2017 |
| Cutaneous metastasis of prostate carcinoma treated with radiotherapy: a case presentation G Mak, M Chin, N Nahar, P De Souza BMC research notes 7, 1-4, 2014 | 21 | 2014 |
| The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: an Australian population-based multicenter study EY He, NJ Hawkins, G Mak, F Roncolato, D Goldstein, W Liauw, ... The oncologist 21 (5), 618-625, 2016 | 18 | 2016 |
| Achieving behaviour change for detection of Lynch syndrome using the Theoretical Domains Framework Implementation (TDFI) approach: a study protocol N Taylor, JC Long, D Debono, R Williams, E Salisbury, S O’Neill, ... BMC Health Services Research 16, 1-6, 2016 | 14 | 2016 |
| Factors Impacting Treatment Choice in the First-Line Treatment of Colorectal Cancer LT Bloem, RA Lourenço, M Chin, B Ly, M Haas Oncology and Therapy 4 (1), 1-14, 2016 | 13 | 2016 |
| Codesigning consumer engagement strategies with ethnic minority consumers in Australian cancer services: the CanEngage Project protocol R Harrison, M Walton, E Manias, C Wilson, A Girgis, M Chin, D Leone, ... BMJ open 11 (8), e048389, 2021 | 10 | 2021 |
| Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment G Mak, HT Arkenau, M Chin Melanoma Research 24 (4), 408-412, 2014 | 9 | 2014 |
| Challenges and solutions to sharing a cancer follow-up e-care plan between a cancer service and general practice J Taggart, M Chin, W Liauw, D Goldstein, A Dolezal, J Plahn, MF Harris Public Health Res Pract 31 (2), 31122108, 2021 | 8 | 2021 |
| What does co-design mean for Australia’s diverse clinical workforce? R Harrison, M Chin, EN She Australian Health Review 46 (1), 60-61, 2021 | 7 | 2021 |
| Assessing suitability for long-term colorectal cancer shared care: a scenario-based qualitative study K Vuong, K Uebel, M Agaliotis, S Jun, J Taggart, S Suchy, W Liauw, ... BMC Family Practice 21, 1-8, 2020 | 7 | 2020 |
| Treatment of breast cancer 2 (BRCA2)-mutant follicular dendritic cell sarcoma with a poly ADP-ribose polymerase (PARP) inhibitor: a case report CR Lemech, R Williams, SR Thompson, B McCaughan, M Chin BMC Research Notes 9, 1-5, 2016 | 7 | 2016 |
| ‘Making it Meaningful’: Co-designing an intervention to improve medication safety for people from culturally and linguistically diverse backgrounds accessing cancer services. A Chauhan, B Newman, E Roberto, RL Walpola, H Seale, M Chin, ... Patient Experience Journal 10 (2), 34-48, 2023 | 5 | 2023 |
Robyn Lynne WardUniversity of Queensland在 unsw.edu.au 的电子邮件经过验证
